Navigation Links
OQAS Optical Quality Analysis System

ProductsOQAS Optical Quality Analysis System
Company Visiometrics
Item OQAS Optical Quality Analysis System
Features OQAS is specially designed for :
  • Comparing pre and post cataract and refractive surgery measurements
  • Diagnosis of pathologies
  • Right measurements of the ocular MTF (Modulation Transfer Function) in all situations (overestimated by aberrometers when scattering exists)
  • Showing the effect of ocular aberrations in visual acuity (including the higher order ones, not usually measured by standard aberrometers)
  • Objective measurement of the amplitude of accommodation
  • Showing the effect of accommodation in the quality of the retinal image
  • Objective measurement of halos and glare

OQAS provides:

  • Two and three dimensional maps of the retinal image, a qualitative way to evaluate the quality of the eye
  • The ocular MTF and other quantitative parameters useful for evaluating the performance of the eye
  • A dynamic register (video) of the retinal image
  • A useful and user-friendly patient database
  • Tools for optimum visualization and quantification of the images, such as zoom, rotation, profiles and measurements
  • Easy acquisition and manipulation of the images
Description OQAS (Optical Quality Analysis System) developed by Pablo Artal, PhD and Jaume Pujol, PhD is the first diagnostic tool for ophthalmology that provides "total optical quality of the total optical system. Never before has an ophthalmologist had the opportunity to truly understand a patients quality of vision.

OQAS works by sending in a near infrared light source and directly measuring the point-spread function of that reflected light source. Using Fourier analysis the point spread function data is translated to an MTF value. OQAS also provides full color, 3-dimensional views of the point spread function.

MTF values (the numeric translation of contrast sensitivity) are the basics of optical quality. For years the photography industry has used MTF values to measure the optical quality of lenses. The higher the MTF value, the higher the quality of the image after it passes through a lens. Transfer this optical knowledge to the eye and now we can know, for the first time, the total optical quality of the eye.

The superiority of OQAS over aberrometers is the ability of the OQAS to measure and analyze all orders of aberration PLUS scatter. Standard aberrometers are incapable of measuring higher order aberrations or scatter. To truly analyze your patients optical quality it is necessary to have complete information.

Applications include: screening of LASIK candidates, comparative studies of excimer lasers, IOL comparative studies, monitoring of cataract formation, comparative studies of different surgical techniques, and most importantly having an objective baseline of your patients optical quality. This objective analysis of optical quality can be used as an adjunct to your current subjective assessment of optical quality.

Info Visiometrics
Customer Service: North America: 530-628-1947; Spain: +34 93 736 32 10
Web site: http://www.visiometrics.com

Related medicine products :

1. IOL Master Optical Biometer
2. Computerized Optical Systems
3. Sola Optical USA
4. Classic Optical Laboratories Inc.
5. Eye-Kraft Optical
6. Omni Optical Lab
7. OTS Optical Tracking System
8. IVR-Optical Tracking System
9. Series 490 Low Cost Automatic Optical Aggregometers
10. STRATUS OCT Optical Coherence Tomography
11. VitalWorks OptiShop Optical shop management system
Short handled spatula for use through the side port stab incision. The malleable silver 0.5 mm tip can be shaped to the surgeon's preference for maximum control. Round serrated handle....
1 mm wide by 28 mm long sterling silver blade. Flat serrated handle with polished finish....
Lasik spatula useful for protecting a previous flap for retreatment to lift and smooth the corneal flap....
Triangular 0.5 mm angled tip with 4 mm flat surface. Round knurled handle with dull finish. Tip angle: 150o....
Medicine Products:
(Date:7/12/2014)... (PRWEB) July 12, 2014 As DePuy ... forward in U.S. courts, Bernstein Liebhard LLP notes the ... ion levels to the failure of metal-on-metal hip replacements. ... of The Journal of Bone & Joint Surgery, looked ... Articular Surface Replacement prostheses at least twelve months earlier. ...
(Date:7/12/2014)... “Critical Care Therapeutics in Major Developed ... PCCs and Recombinant Products to Drive Market,” which ... in the US, UK, France, Germany, Italy, Spain, ... of market size for 2013, along with market ... that are being treated using the five major ...
(Date:7/12/2014)... July 12, 2014 Dubai is buzzing ... legend is heading to the UAE. The National ... will be in the UAE from 28-31 October to ... support of diabetes awareness. The event is being organized ... and event management company based in Dubai. The announcement ...
(Date:7/12/2014)... July 12, 2014 Restore My Vision ... and Samantha Pearson, a couple boasting very impressive credentials ... Restore My Vision Today as a way to help ... have become in their respective patients’ treatments . ... to a “secret” trove of pertinent information relevant to ...
(Date:7/12/2014)... 12, 2014 Ladies, it doesn't matter what ... Those who are looking for an affordable gown can ... occasion dresses) to get their dream items. Recently, the company ... length gowns . Along with that, it is also providing ... the special offer; the deadline of this promotion is July ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 2Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 3Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 4Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 3Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 4Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 5Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 6Health News:Los Angeles Basketball Legend Headed to Dubai 2Health News:Los Angeles Basketball Legend Headed to Dubai 3Health News:Restore My Vision Today | Groundbreaking Book Reveals How To Restore Your Vision Without The Use of Glasses – Vinamy 2Health News:Restore My Vision Today | Groundbreaking Book Reveals How To Restore Your Vision Without The Use of Glasses – Vinamy 3Health News:Worldwide Brides-to-be: It Is Time To Show Your Beauty By Wearing A Trendy Summer Short Wedding Dress From Discount-Dress.com 2
... that the people of India constitute more than ... been underrepresented in studies related //to genetic diseases. ... diseases associated with urban and western lifestyles have ... association studies of particular importance. ,In ...
... comparing the safety, effectiveness and reliability of LASIK and LASEK ... of laser eye// surgery. ,The study, led by ... the December 2006 issue of the American Journal of Ophthalmology. ... safety and efficacy of both types of laser surgery, there ...
... Biology, members of Dr. John Herr’s laboratory at the ... a new protein within a sperm’s tail that could ... ,“There’s considerable interest in developing new male contraceptives,” ... Contraceptive and Reproductive Health. “To support this effort, our ...
... somehow delay the greying process continues with gusto into the ... Youthfulness always pouts with tantalising// appeal. The latest from scientists ... If the DNA within a living cell gets damaged, it ... especially true if the cell is too weak to help ...
... the repercussions of a potential flu pandemic showed that nearly ... nations, could pay// with their life. , ,The ... Spanish flu, which wiped out nearly 20 million people in ... Health and the University of Queensland studied the data gathered ...
... Researcher predict that in the years ahead, medical science ... transform medicine for various treatments will stand to// reshape ... dean of the health-planning department at Eastern Virginia Medical ... based on these technologies. ,'Fat Fryer' Device ...
Cached Medicine News:Health News:Researchers Make Progress in Studying Genetic Traits of India-born Populations 2Health News:Study Compares LASIK and LASEK Eye Surgery 2Health News:Male Contraception: Discovery Stirring Interest Among Scientists, Drug Developers 2Health News:Clues to Allay Aging 2Health News:Medical Science Miracles – Coming Your Wa 2
(Date:7/10/2014)... 10, 2014  Decision Resources Group finds that ... (ID) specialists are willing to prescribe Durata,s Dalvance ... use as OPAT, approximately two-thirds of the respondents ... their hospital inpatients. However, our findings indicate that ... initiated on OPAT following hospital discharge, and most ...
(Date:7/10/2014)... -- Decision Resources Group finds that over half of ... Drug Administration,s (FDA) approval of Vifor Fresenius Medical Care ... by the FDA in November 2013 for the treatment ... dialysis. Other key findings from the report ... : , Bundling: Based ...
(Date:1/15/2014)... Most osteoporosis patients want a choice in the ... sponsored by Mission Pharmacal Company. The survey, conducted by ... support community, revealed that 74 percent of osteoporosis patients ... form other than a pill or a tablet. ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3